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Bacterial lineages that chronically infect cystic
fibrosis (CF) patients genetically diversify during
infection. However, themechanisms driving diversifi-
cation are unknown. By dissecting ten CF lung pairs
and studying12,000 regional isolates, we were able
to investigate whether clonally related Pseudomonas
aeruginosa inhabiting different lung regions evolve
independently and differ functionally. Phylogenetic
analysis of genome sequences showed that regional
isolation of P. aeruginosa drives divergent evolution.
We investigated the consequences of regional evolu-
tion by studying isolates from mildly and severely
diseased lung regions and found evolved differences
in bacterial nutritional requirements, host defense
and antibiotic resistance, and virulence due to hyper-
activity of the type 3 secretion system. These find-
ings suggest that bacterial intermixing is limited in
CF lungs and that regional selective pressures may
markedly differ. The findings also may explain how
specialized bacterial variants arise during infection
and raise the possibility that pathogen diversification
occurs in other chronic infections characterized by
spatially heterogeneous conditions.
INTRODUCTION
Chronic infections involve long-term interactions between bac-
teria and their hosts, some lasting for decades. The chronic
Pseudomonas aeruginosa infections that afflict cystic fibrosis
(CF) patients are a prime example. Although host defenses, anti-
biotic treatment, and expectoration eliminate large numbers of
organisms, bacterial replication keeps pace, enabling a single
P. aeruginosa lineage to persist in a patient’s lungs for life (BurnsCell Host &et al., 2001; Struelens et al., 1993). Landmark studies indicate
that infecting P. aeruginosa evolve within CF lungs during infec-
tion (Smith et al., 2006; Yang et al., 2011). Furthermore, some
common phenotypes are selected for in different strains infect-
ing different patients, despite genetic differences in the strains
and their hosts (Burns et al., 2001; Doggett et al., 1964; Huse
et al., 2013; Smith et al., 2006).
Recent work also shows that infecting P. aeruginosa and
Burkholderia lineages can genotypically and phenotypically
diversify during CF infections (Ashish et al., 2013; Darch et al.,
2015; Lieberman et al., 2014; Williams et al., 2015). Diversity
likely enhances the pathogenic potential of bacterial populations
by enabling rapid, adaptive responses to changes in host condi-
tions including nutrient availability and immune and antibiotic
pressure. However, the mechanisms producing diversification
of infecting lineages and its consequences for disease remain
unknown.
One possibility is that the genetic diversification of bacteria
infecting CF lungs is driven by the isolation of organisms in
different lung regions. Most CF lungs with established infection
contain regions with very mild and very severe disease (Gurney
et al., 1997). If regional populationswere geographically isolated,
they could evolve independently due to differing selective pres-
sures and drift, a process termed genetic compartmentalization.
A precedent for this mechanism exists in human infections. HIV
populations infecting different body sites can be genetically
compartmentalized, and compartmentalization is thought to be
a key driver of viral diversification and disease progression
(Heath et al., 2009; Pillai et al., 2006; Za´rate et al., 2007).
However, organisms can also readily diversify in the absence
of geographic isolation and spatial heterogeneity. The presence
of varied nutrients or temporal fluctuations in conditions strongly
promotes genetic diversification even in well-mixed and spatially
homogenous environments (Jasmin and Kassen, 2007), and
these factors are hallmarks of CF airway conditions.
In this study, we addressed two main questions. First, do
clonally related isolates in different regions of chronically in-
fected CF lungs differ functionally in ways that could affect theirMicrobe 18, 307–319, September 9, 2015 ª2015 Elsevier Inc. 307
pathogenic potential? Second, does the isolation of bacteria
in different lung regions contribute to the divergent evolution
of infecting lineages? To address these questions, we sampled
the upper, middle, and lower lobe airways of lung pairs from
ten CF patients removed at the time of transplantation and
collected 12,000 resident P. aeruginosa isolates for analyses,
which included phenotypic, proteomic, and whole-genome
sequencing studies. We also intensively studied bacteria iso-
lated from mildly and severely diseased lung regions to investi-
gate regional differences in infecting bacteria and their potential
effects on disease.
RESULTS
Lung Dissection to Collect Regional P. aeruginosa
Populations
Lungs were maintained at 4C immediately after removal from
patients, and sampling was completed within hours to limit
ex vivo changes in bacterial abundance. Ten lung pairs were
studied, and both right and left lungs were sampled at three
sites: the upper, middle (lingula), and lower lobe airways. We
devised dissection methods to isolate secretions from the major
lobar airways without cross-sectioning lungs to avoid mixing
regional bacteria. We used blunt dissection to skeletonize the
airways without entering the lumens, flash sterilized the outside
of airway walls, and collected luminal secretions (Figure 1A).
CF Lungs Are Dominated by Single Lineages of
P. aeruginosa
We used 16S rRNA gene sequencing to identify the genera pre-
sent in regional secretions and found that the vast majority of
reads mapped to Pseudomonas species in 8 of the 10 lung pairs
in which these studies were performed (Table S1) (Goddard
et al., 2012). Whole-genome sequence analysis of bacteria
from three lung pairs confirmed that these isolates were
P. aeruginosa (see below).
To broadly sample regional P. aeruginosa, we cultured airway
secretions on selective media and randomly picked 200 col-
onies per region (1,200 per patient). Consistent with previous
work, random amplification of polymorphic DNA analysis indi-
cated that in all but one subject, the P. aeruginosa in each
regional sample belonged to a single lineage (Figure S1A). We
studied these isolate collections using phenotyping, proteomic
analysis, and whole-genome sequencing.
Regional P. aeruginosa Differ in Virulence and
Resistance Phenotypes
To begin examining regional phenotypic differences, we sub-
jected the 12,000 isolates collected from the upper, middle,
and lower lobes of all ten lung pairs to tests measuring heritable
phenotypes, including the production of the virulence factor
rhamnolipid, swimming motility, amino acid auxotrophy, and
resistance to antibiotics.
The proportion of isolates expressing most phenotypes
differed regionally within each lung (Figures 1B, S1B, and
S1C). For instance, 40% of isolates from the right upper lobe
of patient 1 were ciprofloxacin resistant, whereas all studied
right lower lobe isolates were susceptible. Likewise, the left
lower lobe of patient 1 harbored mainly non-motile isolates,308 Cell Host & Microbe 18, 307–319, September 9, 2015 ª2015 Elswhereas nearly all clonally related siblings in the left upper lobe
were motile. Regional differences were also seen in other traits
in all ten lung pairs (Figures 1B and S1B). Thus, regional popula-
tions likely differ markedly in virulence potential and treatment
responses.
Regional P. aeruginosa Populations Are Distinct
In addition to within-lung variation of individual phenotypes, the
data above showed that different phenotypes exhibited distinct
patterns of regional variation. For example, whereas the left
upper lobe in patient 1 contained more ciprofloxacin-resistant
isolates than the lower lobe, these lobes contained a similar pro-
portion of tobramycin-resistant isolates. This could be explained
if lung regions contained mixtures of phenotypic variants.
To test this, we used the phenotypes to classify isolates into
groups (called subpopulations, below) (Figure 1C). For example,
one subpopulation included isolates that produced the surfac-
tant rhamnolipid, were motile, growth-impaired without amino
acids, and resistant to tobramycin, ceftazidime, and ciprofloxa-
cin (Figures 1C and S1D). Other subpopulations were defined
by different results. This classification revealed several findings.
First, the summed results from each lung pair revealed that
every patient’s lungs contained between 12 and 40 subpopula-
tions (Figures 1D and S2). These numbers are likely an underes-
timate as they are based on the results of only six phenotypic
tests.
Second, most lobar regions contained a mixture of subpopu-
lations, with 1–3 subpopulations typically dominating each
region. In only two cases (the right lower lobe of patient 1 and
the right upper lobe of patient 6) were all 200 regional colonies
classified as a single subpopulation (Figures 1D and S2). The
population composition of lobar regions also differed from the
summed (total lung) value (Figures 1D and S2).
Third, regions within individual lungs appeared to have
different subpopulation distributions. To formally test this, we
independently subjected the regional subpopulation distribu-
tions found in each patient’s lungs to Monte Carlo permutation
tests (with 10,000 replicates each). This analysis indicated that
subpopulations were distributed in a non-random manner
across lung regions (p < 0.001) in all ten lung pairs.
Regional Populations Exhibit Marked Proteomic
Differences
The work above enabled us to study a large number of isolates
(12,000 total) and measure the regional expression of pheno-
types. However, many pathogenesis traits cannot be assayed
in high throughput, and the aggregate activity of regional popu-
lations may better reflect local bacterial functioning than mea-
sures of phenotype prevalence. Thus, we used proteomics to
study regional isolate populations in six lungs (three lung pairs)
in an unbiased manner. We independently cultured 200 iso-
lates from each region in identical conditions and then pooled
them by region for proteomic analysis (Figures 2A and S3 and
Table S2). While laboratory culture may not elicit the expression
of some proteins relevant in vivo, the pooling approach enabled
genome-wide protein expression comparisons of regional popu-
lations. Furthermore, expression changes had to be heritable
and of substantial magnitude to be detected in ex vivo cultures
of isolate mixtures.evier Inc.
Figure 1. Regional Populations Vary in Infection Phenotypes
(A) Lung dissection method. Bronchi were isolated by dissection, bronchial walls flash sterilized, and airway lumens lavaged with saline.
(B) The proportion of regional isolates expressing indicated phenotypes (see Figures S1B and S1C).
(C) Heritable differences in phenotypes categorized P. aeruginosa into subpopulations (see Figure S1D). Rhamnolipids were indicated by a colony halo,
swimming by the clouding of wells, growth onminimal media, and antibiotic resistance by growth on selective plates. Columns show single colonies subjected to
different tests.
(D) The relative abundance of P. aeruginosa subpopulations in regional samples and in all regions combined (Total lung); colors indicate distinct subpopulations.The proteome measurements revealed that clonally related
populations from different lung regions did manifest significant
protein expression differences (Figures 2A and S3 and TableCell Host &S2). For example, 26% (220/844) of the detected proteins from
patient 1 exhibited a 2-fold or greater difference in relative
expression level in at least two lung regions (p < 0.01, one-wayMicrobe 18, 307–319, September 9, 2015 ª2015 Elsevier Inc. 309
Figure 2. Regional Populations Have Distinct Proteomes
(A) Expression profiles of the 50 proteins showing the greatest expression differences between regional isolate populations (populations = pools of 200 clonally
related P. aeruginosa collected from lobar airways). Relative protein expression is indicated in comparison to the median abundance protein (black, median; red,
high; green, low). Gene and protein names of PAO1 homologs are indicated (see Table S2 and Figure S3).
(B) Principal component analysis indicates that pools of isolates found together have more similar expression profiles than those found apart.ANOVA). Eleven percent (90/844) of the detected proteins
differed in expression by at least 4-fold. The isolates from pa-
tients 2 and 3 showed similar differences. In patient 2, 168/742
proteins (23%) and in patient 3, 139/724 proteins (19%) showed310 Cell Host & Microbe 18, 307–319, September 9, 2015 ª2015 Elsa 2-fold or greater difference in expression in at least two lung
regions (p < 0.01, one-way ANOVA) (Figure 2A and Table S2).
In vivo protein expression profiles of regional populations will
likely differ even more due to the combined effects of heritableevier Inc.
Figure 3. Regional P. aeruginosa Are Genetically Compartmentalized
(A–C) Phylogenetic trees were constructed from whole-genome sequences of regional P. aeruginosa from patients 1 (A), 2 (B), and 3 (C), and the number of
bacterial migrations needed to account for the observed population distributions are indicated with red arrows. Colors of leaves indicate the lung region where
each isolate was collected, scale bar indicates number of SNPs per variable position, and ‘‘*’’ indicates most genetically divergent isolates in each lung. Graphs
indicate the frequency distributions for the number of migrations needed to account for each of 999,999 randomly generated trees.differences in regional isolates and different local growth
conditions.
We also used the proteomics data to investigate whether
isolates found together exhibit a greater degree of functional
similarity than isolates found in different regions. To accomplish
this, we randomly divided the isolates from individual lung re-
gions of patients 1 and 4 into two groups of 100 isolates each
(indicated as A and B groups), grew the groups independently,
and compared their proteomic profiles. The groups were
compared using principal component analysis with the regional
populations as variables and the protein expression values
serving as observations. As shown in Figure 2B, isolate groups
from the same region generally clustered more closely together
than groups found apart, in each patient.
Regional P. aeruginosa Populations Evolve
Independently
The data above indicate that P. aeruginosa from different regions
exhibit distinct phenotype and protein expression profiles, while
bacteria inhabiting the same regions have similar proteomic
profiles. These findings, along with the known marked regional
heterogeneity of disease in infected CF lungs (Gurney et al.,
1997), led us to hypothesize that the P. aeruginosa inhabiting
different lung regions evolve independently. IndependentCell Host &regional evolution can cause co-localizing organism to have
greater DNA sequence relatedness than those found apart,
which is known as genetic compartmentalization.
To test for compartmentalization, we randomly picked 96 iso-
lates from the upper, middle, and lower lung lobes from patients
1–3 and sequenced their genomes (288 isolates in total). The
whole-genome sequence data were used to construct phyloge-
netic trees with a k-mer-based approach (Gardner and Hall,
2013). Notably, the P. aeruginosa lineages from patients 2 and
3 contained large numbers of single-nucleotide polymorphisms
(SNPs), and all 96 sequenced isolates from these patients were
found to have frameshift mutations in DNA mismatch repair
genes (mutS and mutL, in patients 2 and 3, respectively).
Furthermore, individual isolates from patients 2 and 3 had
elevated mutation frequencies (Figure S4A). The evolution of
‘‘hypermutator’’ lineages occurs commonly during CF (Oliver
et al., 2000). Thus, our phylogenetic analysis included lineages
with high and low mutation frequencies.
In all three phylogenies, bacteria generally clustered into
clades based on the region they were collected from (Figures
3A–3C), which is characteristic of genetic compartmentalization.
We measured the degree of compartmentalization by subjecting
the phylogenetic trees to the Slatkin-Maddison analysis (Slatkin
and Maddison, 1989). This analysis assumes that the mostMicrobe 18, 307–319, September 9, 2015 ª2015 Elsevier Inc. 311
Table 1. Mutation Accumulation in Longitudinal Sputum and
Regional Lung P. aeruginosa
Studies of Longitudinal P. aeruginosa
Clonal group SNPs/year Reference
‘‘PA14’’ clone 1 Cramer et al., 2011
DK2 2.5 Marvig et al., 2013
PACS2 5.5 Smith et al., 2006
CFA and CFD
hypermutators
100 Feliziani et al., 2014
Clone C hypermutator 50 Cramer et al., 2011
Studies of Regional P. aeruginosa
Lung transplant
lineage (from this study)
Total SNPs
per lineagea
SNPs differentiating
divergent isolatesb
Patient 1 328 63 (LU versus LL)
Patient 2 3169 549 (LG versus LL)
Patient 3 1653 592 (LG versus LL)
aTotal SNPs include nonsynonymous and synonymous SNPs in genes
and intergenic regions.
bRegions where divergent isolates were collected are indicated in paren-
theses: LU, left upper lobe; LL, left lower lobe; LG, lingual.closely related organisms share a common ancestor that occu-
pied a single location. If the closely related organisms are found
in different locations, then a migration event is assumed. The
number of migrations required to account for the observed
isolate distribution is then compared to the number required
for randomly permuted trees. The probability that the observed
distribution could be produced by chance gauges the extent of
compartmentalization.
Because the presence of sibling bacteria in lung regions could
inflate the signal of compartmentalization (Korber et al., 2009),
we removed isolates that could be siblings from the analysis
(see Experimental Procedures). Despite this, far fewer migra-
tions were detected between the six regional subpopulations
than expected by chance (p < 0.000001) in all three lung pairs
studied, including those with increased mutation frequencies
(Figure 3). This was notable because elevated mutation fre-
quency may increase the sensitivity with which migrations can
be detected.
To put these results into context, the p values we obtained
from the Slatkin-Maddison analyses exceeded that typically
detected in HIV populations (p values 0.037 to < 0.001) (Heath
et al., 2009; Pillai et al., 2006; Za´rate et al., 2007). HIV is the
paradigm human infection in which pathogen genetic com-
partmentalization due to limited migration has been described.
In HIV, rapid replication, high mutation rates, long infection
periods, and highly disparate infecting locations (e.g., CNS
neurons versus genital tract tissue) are thought to be
responsible (Heath et al., 2009; Pillai et al., 2006; Za´rate
et al., 2007). Our data show that P. aeruginosa populations
in different airway locations may be even more strongly
compartmentalized.
Extensive Genetic Differences Can Arise in Regional
P. aeruginosa
In addition to testing for compartmentalization, the sequence
data enabled us to estimate the extent of P. aeruginosa genomic312 Cell Host & Microbe 18, 307–319, September 9, 2015 ª2015 Elsvariation within CF lungs. We began with patient 1, whose in-
fecting lineage did not manifest the hypermutator phenotype.
We measured overall genetic diversity among each of the 96
sequenced P. aeruginosa isolates from this patient using the
genome analysis toolkit (McKenna et al., 2010) and found a total
of 328 SNPs. We also gauged the extent to which isolates occu-
pying different lung regions differed genetically. In patient 1, the
most divergent sequenced isolates came from the left upper
and left lower lobes (‘‘*,’’ Figure 3A), and these isolates differed
by 63 SNPs.
As expected, the hypermutator lineages from patients 2 and 3
exhibited greater variation. The 96 isolates sequenced from pa-
tients 2 and 3 contained a total of 3,169 and 1,653 SNPs, respec-
tively. A right lower lobe and lingula isolate were most divergent
in patient 2, differing by 549 SNPs; a left lower lobe and lingula
isolate were most divergent in patient 3, differing by 592 SNPs
(‘‘*,’’ Figures 3B and 3C). Notably, no two sequenced strains
were identical over the entirety of their analyzed genomes in
any of the three lung pairs studied.
The degree of regional variation may be put into context by
comparison to longitudinally collected CF P. aeruginosa isolates
(Table 1). Previous studies examining strains without the hyper-
mutator phenotype detected between 1.1 and 5.5 SNPs per year
in serially collected isolates (Cramer et al., 2011; Marvig et al.,
2013; Smith et al., 2006), while studies of hypermutator lineages
detected between 40 and 100 SNPs per year (Cramer et al.,
2011; Feliziani et al., 2014). Thus, clonally related P. aeruginosa
lineages coexisting in different lung regions could have diver-
gently evolved over many years (Table 1). Furthermore, the 96
isolates sequenced per lung contained roughly 20- to 150-
fold more SNPs than estimated to develop per year. While
directly comparing the diversity detected as a function of time
and spatial location is difficult, the findings suggest that infected
lungs likely retain isolates that have evolved over prolonged time
periods.
Regional Evolutionary Differences Appear
Individualized
CF isolates from different patients evolve some common traits
(Huse et al., 2010, 2013; Marvig et al., 2015; Smith et al., 2006;
Yang et al., 2011), which is evidence of adaptation due to
common selective pressures. Furthermore, the nature of adap-
tive phenotypes shed light on key selective pressures. Thus,
we used our phenotypic, proteomic, and genomic data to deter-
mine if certain variations were associated with particular lung
regions. For the phenotypic and proteomic data, we focused
on comparisons between the upper and lower lobes, as CF
lung disease typically begins earlier and is more severe in the
upper than lower lobes (Gurney et al., 1997). Thus, these areas
may represent disease extremes.
The phenotypic data showed no consistent pattern in the up-
per and lower lobe distribution of phenotypes in the ten lung
pairs for which analyses were performed (Figures 1B and S1B).
For example, in the left lungs of patients 1 and 3, the upper lobes
contained a greater proportion of ciprofloxacin-resistant isolates
thanmiddle or lower lobes. However, this pattern was not seen in
the right lung of patient 3 or either lung of patient 2. Likewise,
averaging the data from all ten lung pairs found no difference
in the ciprofloxacin and tobramycin resistance of isolates fromevier Inc.
Figure 4. Regional Adaptation Leads to Localized Mutations
(A) Localized mutations disproportionately affect genes involved in environ-
mental interactions. Functional categories enriched in localized mutations (p <
0.05, Fisher’s exact test) are shown as offset pie wedges and are highlighted in
red. The total numbers of localized P. aeruginosamutations in each patient are
shown below each pie chart (see Table S3). The PAO1 chart indicates the
relative abundance of functional categories and the number of genes.
(B) The regional distribution of localized mutations in lungs from patients 1–3.the upper, middle, or lower lobes (Figure S1C). Thus, while the
phenotypes of regional isolates within individual lungs differ
markedly, no consistent regional patterns were apparent in the
ten lung pairs we studied.Cell Host &We also identified the 50 proteins showing the largest expres-
sion differences between upper and lower lobe P. aeruginosa
populations, as these could reveal region-specific adaptations
(Figure 2A). However, none of the proteins showing marked up-
per-lower lobe differences were common to all six lungs studied.
Furthermore, only 3.4% (21/621) of the proteins showing signif-
icant expression differences in at least two lung regions were
common to all six lungs (Table S2). These data show that while
protein expression by regional P. aeruginosa populations
differed significantly, consistent regional expression patterns
were not apparent.
Finally, we examined the genome sequencing data and were
unable to find any genes that had mutations in all isolates
collected from the same region in all patients. We subsequently
used more permissive criteria and defined genes with ‘‘localized
mutations’’ as those with nonsynonymous SNPs or insertions/
deletions in more than half of the isolates from a single region
but fewer than 50% of the isolates in other regions (Table S3).
Notably, most genes containing localized mutations were anno-
tated as mediating environmental interactions, such as the
production of secreted factors; cell wall, LPS, and capsule syn-
thesis; and small molecule transport (Figure 4A). Analysis of the
localized mutations with SnpEff (Cingolani et al., 2012) predicted
that most would have moderate effects on protein function
(Figure S4B). In addition, it was interesting that a single region
in each of the three lung pairs studied contained most of the
localized mutations (the left upper lobes of patients 1 and 2,
and the left lower lobe of patient 3) (Figure 4B).
However, even using the permissive definition of localized
mutations, none of the three lung pairs contained the same local-
izedmutations in the same regions. Indeed, none of the localized
mutations were shared by all three lung pairs, irrespective of re-
gion. Nineteen genes did exhibit localized mutations in 2 of the
3 patients studied (Table S3), but these were not found in the
same regions. It is possible that conserved regional changes
would become apparent if a larger number of lungs were exam-
ined, or through comparisons made on the basis of conditions,
rather than lung location. However, it is also possible that
regional changes exhibit a high degree of individual variability.
An Intensive Analysis of Regional Lung Evolution
While genomic studies can identify associations between path-
ogen variation and geographic location, understanding the
genetic basis and consequences of regional evolution requires
studying individual isolates. This may be particularly important
if region-specific adaptations prove to be highly individualized,
as suggested by the studies above.
To study regional variation in depth, we examined individual
P. aeruginosa variants from the left upper and lower lobes of
our first patient’s lungs, as lung imaging showed that the upper
lobe exhibited more damage than the lower lobe (Figure 5A).
We focused on isolates from the numerically dominant subpop-
ulations in these regions for two reasons. Abundant isolates may
be most likely to be adapted to local conditions, as adaptation
could increase reproductive success. In addition, abundant
isolates may be most likely to affect regional disease. Thus, we
picked isolates classified as members of the dominant subpop-
ulations collected from the left upper and lower lobes, respec-
tively (Figure 1D, patient 1, purple and blue bars). We refer toMicrobe 18, 307–319, September 9, 2015 ª2015 Elsevier Inc. 313
Figure 5. The Upper and Lower Lobe Isolates Differ in Pathogenesis Phenotypes
(A) Computed tomography scans of a healthy left lung, and the left lung of CF patient 1 showing characteristic severe disease in the upper andmild disease in the
lower lobes.
(B) Growth over time in media containing indicated carbon and nitrogen sources, as measured by phenotype microarrays (red, upper lobe isolate; green, lower
lobe isolate; yellow, overlap; see Figure S5A).
(C) Ciprofloxacin MIC of the lower lobe, upper lobe, and upper lobe isolate with a corrected parE gene (see Table S4).
(D–F) The upper lobe isolate is compared to the lower lobe isolate, or the upper lobe isolate in which wild-type exsD is restored. Results are representative of three
or more experiments. (D) Cytotoxicity to A549 epithelial cells as measured by LDH release, relative to detergent-treated cells (set at 100%). Also included are PAK
(positive control), the PAK exsA mutant (negative control), and the left lower lobe isolate with exsD T188P (mean ± SEM). (E) Mouse mortality following intra-
tracheal infection (upper lobe isolate, circle; lower lobe isolate, square; upper lobe isolate with wild-type exsD restored, diamond). (F) Bacterial survival after
exposure to human neutrophils (upper lobe isolate, circle; lower lobe isolate, square; upper lobe isolate with wild-type exsD restored, diamond).
(G) Bacterial survival after treatment with human serum.
(H) Macrophage IL-1b release after exposure to bacteria.
(C)–(H), *p < 0.05, paired Student’s t test; (F)–(H), mean ± SD.
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these as ‘‘upper lobe’’ and ‘‘lower lobe’’ isolates below and used
three general approaches to compare them.
First, to broadly survey functional differences, we measured
2,000 nutritional and stress resistance traits and found that
the upper lobe and lower lobe isolates differed in their ability to
use carbon, nitrogen, and energy sources and in pH and osmotic
stress tolerance (Figures 5B and S5A). In some conditions the
upper lobe isolate was more fit, while in others the lower lobe
isolate was more fit.
Second, we compared the isolates’ antimicrobial susceptibil-
ities and found that whereas the upper lobe isolate exhibited
enhanced resistance to ciprofloxacin, aztreonam, and ceftazi-
dime, the lower lobe isolate was more resistant to tobramycin
(Figure 5C and Table S4).
Third, we examined pathogenesis phenotypes. To compare
the isolates’ cytotoxicity and virulence, we incubated them
with epithelial cells, macrophages, neutrophils, and in a murine
lung infection model. The upper lobe isolate was more cytotoxic
to epithelia andmacrophages (Figures 5D, S5B, and S5C). It was
also more virulent in vivo, as it rapidly killed mice, whereas the
lower lobe isolate did not (Figure 5E). Furthermore, the upper
lobe isolate actually grew during neutrophil exposure, while the
lower lobe isolate was rapidly killed by neutrophils (Figure 5F).
The upper lobe isolate was also more resistant to human serum
(Figure 5G and S5D). Notably, the upper lobe isolate induced
more IL-1b secretion by macrophages than the lower lobe
isolate (Figure 5H), suggesting that its cytotoxicity could come
at the cost of increased immune triggering. Together these
data show that isolates from numerically dominant subpopula-
tions inhabiting the upper and lower lobes exhibited marked dif-
ferences in growth capacity, stress and antibiotic tolerance, and
virulence.
Single-Nucleotide Variations Markedly Affect
Pathogenesis and Resistance Phenotypes
We examined the whole-genome sequence data to identify the
genetic basis of upper and lower lobe isolate phenotypes and
found that the isolates differed by 19 SNPs (Table S5) and a
125-kb deletion. We focused on understanding one of the antibi-
otic resistance phenotypes and the cytotoxicity, as these traits
were likely to affect disease progression.
The upper lobe isolate contained a SNP in the ciprofloxacin
target topoisomerase parE (Lee et al., 2005a), and whole-
genome sequence data showed that the parE mutation was
largely restricted to upper lobe isolates (Figure 6A and Table
S3). Restoring the wild-type (WT) allele markedly reduced cipro-
floxacin resistance (Figure 5C).
The upper lobe isolate also contained a SNP (T188P) in exsD, a
key negative regulator of the type 3 secretion (T3S) system
(McCaw et al., 2002), which is among the most potent bacterial
virulence factors (Lee et al., 2005b). To determine if the exsDmu-
tation was a chance finding limited to one or a few patient 1 up-
per lobe isolates, we PCR amplified exsD directly from regional
lung secretions from patient 1’s lungs (without a culturing step)
and sequenced amplicons to measure WT and variant allele
frequencies (Figures 6B and S6A). The regional abundance of
the exsD T188P allele varied from 0% to 21% of measured
amplicons with the highest abundance in the left upper lobe in
patient 1. The whole-genome sequence data (Table S3) alsoCell Host &showed that the exsD T188P allele was present in 10/13 of the
sequenced isolates from the left upper lobe but only 3/47 isolates
found elsewhere. Furthermore, the exsD T188P mutation was a
defining mutation for a clade that contained most of the left up-
per lobe isolates (Figure 6A).
Finding a mutation in a negative regulator of T3S was notable,
because T3S is generally thought to be inactivated in established
CF infections (Hu et al., 2013; Jain et al., 2008). Thus, we inves-
tigated whether themutation could disrupt the inhibitory effect of
exsD. When expressed in a reference laboratory strain, the exsD
T188P allele failed to repress T3S gene and protein expression
(Figures S6B and S6C). Consistent with this finding, the upper
lobe isolate (which has the exsD T188P allele) expressed higher
levels of T3S proteins than the lower lobe isolate (Figure 6D).
Furthermore, restoring the WT exsD allele in the upper lobe
isolate eliminated unregulated T3S gene and protein expression
(Figures 6C, 6D, S6B, and S6C), decreased resistance to killing
by phagocytes (Figure 5F), and reversed epithelial and macro-
phage cytotoxicity (Figurse 5D, S5B, and S5C) and the lethal
murine infection phenotype (Figure 5E).
We also introduced the exsD T188P mutation into the lower
lobe isolate and found that it increased production of T3S
proteins (Figure S6D), increased epithelial cell cytotoxicity (Fig-
ure 5D), and markedly increased virulence in the murine pneu-
monia model (Figure S6E). Thus, a single point mutation that
arose in a regional clade markedly increased the cytotoxicity,
neutrophil resistance, and inflammatory potential of regional
isolates.
To determine if increased T3S activity was apparent when the
diluting effects of other (T3S negative) regional variants were ac-
counted for, we compared the T3S protein abundance in pools
containing 200 left upper and lower lobe P. aeruginosa isolates
from patient 1 using quantitative selective reaction monitoring
mass spectrometry. The left upper lobe pool showed much
higher expression of T3S proteins than the left lower lobe
(Figure 6E). Notably, the pooled right upper lobe P. aeruginosa
population also produced more T3S proteins than the right
lower lobe population (Figure S6F). However, whole-genome
sequencing of ten right upper lobe isolates and exsD amplicon
sequencing suggested that an exsD mutation was not likely
responsible (Figure 6B and Table S3). This finding raises the pos-
sibility that an increased T3S phenotype evolved independently
in the left and right lungs in patient 1.
DISCUSSION
Genetic diversity can evolve through mechanisms that involve,
or are independent of, spatial heterogeneity. Our study of CF
lung P. aeruginosa indicates that isolation in different lung
regions is a key factor driving their diversification. This conclu-
sion is based on several findings: (1) regional P. aeruginosa
genome sequences demonstrated strong signals of genetic
compartmentalization, indicating divergent regional evolution;
(2) regional P. aeruginosa exhibited more similar protein expres-
sion profiles to each other than to populations from different
regions; (3) the phenotypic profiles of regional P. aeruginosa
showed spatially distinct distributions.
Our study had several limitations. First, we dissected lungs
with advanced disease removed for transplantation. It isMicrobe 18, 307–319, September 9, 2015 ª2015 Elsevier Inc. 315
Figure 6. The exsD Mutation Causes Type 3 Secretion Hyperactivity
(A) The exsD T188P and parE S457R mutations are found in patient 1 left upper lobe and lingula isolates (indicated by gray box).
(B) Relative abundance of exsD T188P variant alleles in regional lung secretions from patient 1 as measured by amplicon sequencing (see Figure S6A).
(C) b-galactosidase activity of the PexsD-lacZ transcriptional reporter (which measures T3S gene expression) in the absence or presence of the T3S inducer EGTA
(mean ± SD, see Figures S6B and S6C).
(D) Western blots of T3S proteins expressed under non-inducing and inducing conditions (± EGTA) in the laboratory strain PAK (positive control), a PAK exsA
mutant (negative control), the lower lobe isolate, the upper lobe isolate with the exsD T188Pmutation, and the upper lobe isolate with a wild-type exsD. ‘‘Control’’
represents a non-specific protein that serves as a loading control, and ‘‘Sup.’’ indicates culture supernatants. Data in (C) and (D) are representative of three
experiments.
(E) Selective reaction monitoring mass spectrometry measurements of T3S and control (AtpD and TufA) proteins in pooled left upper (pink) versus left lower lobe
(burgundy) isolate populations (200 isolates each). Protein abundance was normalized to the summed fragment ion intensity including both upper and lower
lobes. Error bar indicates the abundance range from measurements on different peptides for each protein (see Figure S6F).possible that findings would be different at earlier disease
stages. Second, we sampled only six regions per lung pair
because avoiding cross-contamination required that airways
be large enough to be grossly dissected. Third, the sampled
airways likely contain a mix of bacteria from distal regions.
However, this limitation would likely cause the extent of
genetic compartmentalization to be underestimated. Finally,
we were unable to detect regional phenotypic, proteomic, or
genetic signatures that were shared by all patients. This may
be due to a limitation in the numbers of subjects studied. It is
also possible that regional evolutionary changes are highly
individualized.
What Causes Regional P. aeruginosa to Evolve
Independently in CF Lungs?
A key factor promoting spatially independent evolution is
restricted trafficking of organisms between regions. Limited
intermixing of CF lung P. aeruginosa could be due to physical
separation by factors such as thick mucus, airway obstruction,
or the large distances between regions. The effect of such phys-
ical barriers may be accentuated by loss of bacterial motility,316 Cell Host & Microbe 18, 307–319, September 9, 2015 ª2015 Elswhich occurred frequently in sampled isolates. Directional mu-
cociliary clearance could also contribute, as mixing may require
bacterial movement against mucus flow.
Once trafficking is limited, regional organisms can diverge
because of drift or selection, and it is likely that both mecha-
nisms contribute. Several points suggest that selection is a
key factor. First, lung conditions are known to be heteroge-
neous; normal lungs differ regionally in oxygen and carbon
dioxide tension, and antibiotics achieve different regional
concentrations (Hutschala et al., 2013; Martin et al., 1953). Dis-
ease likely accentuates these differences and may also pro-
duce variation in inflammation and nutrient supply. Second,
we found that localized mutations primarily affected environ-
mental interactions, such as the production of secreted factors
or small-molecule transport functions. Third, in all ten lung
pairs, spatially separated P. aeruginosa differed in phenotypes
important for pathogenesis (such as virulence factor produc-
tion, motility, and resistance). Finally, the phenotypes of vari-
ants from mildly and severely diseased lung regions of the
lung we studied most intensively appeared related to regional
disease conditions.evier Inc.
How Could Regional Evolution Affect Disease?
Our data show that regional P. aeruginosa evolve independently.
While the consequences of independent regional evolution of CF
P. aeruginosa populations are unknown, below we discuss work
in other systems that shed light on how regional evolution could
affect disease.
Regional Evolution May Increase Bacterial Diversity
Adaptation to spatially heterogeneous environments can in-
crease the rate and extent of bacterial diversification in vitro.
For example, P. fluorescens growing in tubes that were held
static to produce spatially heterogeneous conditions evolved
more diversity than identical clones grown with continuous
shaking (Rainey and Travisano, 1998). Similar results were ob-
tained by passaging bacteria on plates, so long as spatial posi-
tioning was maintained over generations (Habets et al., 2006).
Spatially distinct lung conditions could have a similar effect.
Even if regional lung conditions are similar, isolation can promote
diversity, as separated populations may independently undergo
genetic drift (Hoskin et al., 2005).
Regional Evolution May Promote Antibiotic Resistance
Compartmentalized evolution is thought to promote drug resis-
tance (Si-Mohamed et al., 2000). For example, tissues that
contain sub-inhibitory antibiotic concentrations may select for
partially resistant strains that could then spread to compart-
ments with higher antibiotic concentrations and evolve more
resistance (Kepler and Perelson, 1998). This scenario is sup-
ported by studies in HIV where reduced drug penetration in the
genital tract may produce sub-lethal but selective drug levels
that promote anti-viral resistance (Kepler and Perelson, 1998;
Si-Mohamed et al., 2000).
Regional Evolution May Promote Tissue Tropism and
Virulence
In HIV infections and solid tumors, regional adaptation is thought
to promote the evolution of virus or neoplastic cells with
increased injury potential. In the brain, HIV adhesins evolve
and may increase viral entry into neurons, and thus local replica-
tion (Pillai et al., 2006). Harsh local conditions such as hypoxia
and acidosis in tumors has been postulated to have similar ef-
fects, selecting for mutations that increase invasiveness and
dissemination capacity (Gatenby and Gillies, 2004; Junttila and
de Sauvage, 2013). Our finding that isolates with T3S hyper-
activity evolved in a region of severe disease is another example
of how local evolution could increase virulence and influence dis-
ease progression.
We speculate that for both virulence and drug resistance phe-
notypes, regional evolution due to compartmentalization may
have the greatest effect on disease if mixing is limited, but not
eliminated, which our data suggest is the case in CF. Limited
mixing could enable local populations to have sufficient expo-
sure to regional conditions to select for variants, and yet some
variants could migrate elsewhere to influence disease. For
example, resistant variants could evolve where antibiotic pene-
tration is poor, and then sustain infection in compartments that
contain lethal levels. Likewise, cytotoxic variants could evolve
as a consequence of local inflammation or nutrient deprivation,
and then be highly injurious when transferred to less diseased
areas. Consistent with this idea, we found that isolates with
T3S hyperactivity and ciprofloxacin resistance appeared to arise
in one lung region, but migrate to others.Cell Host &Conclusions
Together, our sequencing, proteomics, and phenotyping ana-
lyses indicate that regional P. aeruginosa populations within CF
lungs divergently evolve, producing extensive diversity in patho-
genesis phenotypes. These findings raise the possibility that
local conditions could generate a multitude of specialized vari-
ants that together increase the ability of infecting bacteria to
adapt to changing conditions. In addition, the findings suggest
that clinical events like disease flares could be caused by the ac-
tivities of certain regional populations and that treatments and
host responses that work in one area may be ineffective else-
where. Thus, for both research and clinical purposes, CF lung
disease may be best considered a collection of regional infec-
tions, with different virulence, inflammatory, and resistance
traits. If bacteria causing wound, prostate, sinus, and other
chronic infections also become isolated in areas with differing
conditions, similar diversification mechanisms and disease
consequence may occur.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Media, Growth Conditions, Lung Sampling, and
Genetic Manipulation
P. aeruginosa lab strains (PAO1, PAK, and PA103) were used where indi-
cated for genetic manipulation, or as controls. Prior to lung transplantation,
patients provided informed consent (University of Washington IRB approval
#35663). Sample collection, bacterial genetic manipulations, and bacterial
growth and preservation conditions are described in the Supplemental
Information.
P. aeruginosa Genotyping, Phenotyping, and Proteomic Analysis
Isolated colonies were confirmed to be P. aeruginosa by PCR; clonal rela-
tionships were determined by RAPD (Mahenthiralingam et al., 1996); and
virulence, antibiotic resistance, murine infection, and phenotype microarray
(PM) analysis were performed as described in the Supplemental Informa-
tion. Hypermutation tests were performed as described previously with
minor modifications (Macia´ et al., 2005). For proteomic analysis, indi-
vidual colonies were harvested, proteins extracted and digested and
purified with C18 Sep-Pak columns, and LC-MS/MS was performed with
NanoAcquity UPLC (Waters) and LTQ-XL mass spectrometer (Thermo).
SRM data were acquired with LTQ-XL mass spectrometer using SRM
scan type mode. Additional information is provided in the Supplemental
Information.
Sequencing, Variant Analysis, Migration Analysis, and Allele
Frequency Measurements
We sequenced 96 isolates randomly selected from the isolates collected
from three lung pairs using Illumina sequencing. To identify variant alleles
in isolates from patient 1, BWA and GATK were used to align sequencing
reads from individual isolates to a draft assembly of a single isolate from
the left upper lobe of patient 1 (Li and Durbin, 2009; McKenna et al.,
2010). The P. aeruginosa PAO1 genome was used as a reference for patient
2 and 3 isolates, due to the large numbers of mutations in these hypermu-
tator lineages. SnpEff was used to predict effects of SNPs (Cingolani et al.,
2012). A k-mer-based approach using kSNPs v2 was used to construct
phylogenetic trees for each lineage (Gardner and Hall, 2013). For patient
2 and 3 isolates, phylogenetic trees were constructed using only core
genome SNPs with sufficient sequencing depth in all strains analyzed
(see Supplemental Information).
Slatkin-Maddison migration analysis was conducted with HyPhy using the
phylogenetic trees generated by kSNPs v2 (Gardner and Hall, 2013; Pond
et al., 2005). Strains in each tree were labeled according to their region of
isolation (i.e., left upper, lingula, left lower, right upper, or right lower). The
number of migrations observed in the phylogenies was calculated with HyPhy,
followed by 999,999 permutations of the trees to generate a GaussianMicrobe 18, 307–319, September 9, 2015 ª2015 Elsevier Inc. 317
distribution reflecting the number of migrations expected by chance. For allele
frequency measurements, total DNA was isolated from explant secretions,
exsD was PCR amplified, and sequencing libraries were prepared and
sequenced on an Illumina MiSeq to greater than 1,000-fold coverage. See
Supplemental Information for additional information.
Serum Killing, PMN Killing, LDH Release, IL-1b ELISAs, and Murine
Lung Infections
P. aeruginosa survival was assayed after incubation with PMNs and serum by
viable counts. Cytotoxicity was measured by LDH release from macrophages
and epithelial cells exposed to P. aeruginosa. Macrophage IL-1b production
was measured by ELISA. In all experiments using tissue culture cells, low
serum (2.5%) or serum-freemedia were used. Murine lung infections were per-
formed using C57BL/6 mice (n = 8 mice per group), and mice were observed
for morbidity (see Supplemental Information). Human PMNs and macro-
phages were collected from healthy volunteers (approved by the University
of Washington Institutional Review Board).
Molecular Cloning
Molecular cloning of P. aeruginosa parE and exsD complementation con-
structs and exsD transcriptional reporter fusions was performed using stan-
dard techniques (see Supplemental Information).
T3S Gene and Protein Expression Analyses
P. aeruginosaWT, clinical isolate, and control strain exsD gene expressionwas
measured using a lacZ transcriptional reporter. T3S protein expression was
quantified by immunoblotting (see Supplemental Information).
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